|
All Business Categories
|
CeNeS Pharmaceuticals plc
CB24, United Kingdom CeNeS Pharmaceuticals plc (AIM: CEN), the biopharmaceutical company developing a new generation of pain management products, announces interim results for the six months ended 30 J... Vical Incorporated California, USA Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. P... Locus Pharmaceuticals , Inc. Pennsylvania, USA Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus combines power... VASTox plc Oxfordshire, United Kingdom VASTox is a chemical genomics technology company that provides services to the pharmaceutical industry and discovers and develops proprietary novel drugs. The company's technology ... Genaera Corporation Pennsylvania, USA Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Research and development efforts are f... New Jersey, USA Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, sc... Neuromed Technologies Inc. British Columbia, Canada Neuromed is a privately held biopharmaceutical company developing the next generation of chronic pain drugs with pipeline programs in anxiety, epilepsy and cardiovascular disease s... Cytokinetics , Incorporated California, USA Cytokinetics is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The... The Avicena Group , Inc. California, USA The Avicena Group, Inc. (OTCBB: AVGO) is a late stage, revenue generating biotechnology company focused on developing products based on its proprietary understanding of the regulat... Palatin Technologies , Inc. NEW, USA Palatin Technologies, Inc. is a biopharmaceutical company primarily engaged in the development of melanocortin-based therapeutics. The Company's lead product candidate,bremelanotid...
First
Prev
[2]
[3]
[4]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
16
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[740]
[1455]
[2170]
Next
Last
|
